Plasma lipoprotein(a) levels in patients with slow coronary flow

Simple item page
dc.contributor.authorYucel H.
dc.contributor.authorDogan A.
dc.contributor.authorAltinbas A.
dc.contributor.authorAkcay S.
dc.contributor.authorIcli A.
dc.contributor.authorCeyhan B.M.
dc.date.accessioned2024-07-22T08:17:39Z
dc.date.available2024-07-22T08:17:39Z
dc.date.issued2013
dc.description.abstractIntroduction: Slow coronary flow (SCF) is a microvascular disorder characterized by delayed opacification of coronary vessels with normal coronary angiogram. It may be due to endothelial dysfunction and diffuse atherosclerosis. Lipoprotein(a) [Lp(a)] is related to cardiovascular events. Plasma Lp(a) levels have not been studied previously in SCF patients. Aim: We investigated plasma Lp(a) and fibrinogen levels, and their relation to coronary flow rate in patients with SCF. Material and methods: This cross-sectional study included 50 patients with SCF and 30 age- and sex-matched controls who had normal coronary arteries and normal flow. Coronary flow rates of patients and controls were counted with the thrombolysis in myocardial infarction (TIMI) frame count. Plasma Lp(a) and fibrinogen levels were measured in SCF patients and controls, with routine biochemical tests. Results: There were no significant differences between the two groups with respect to plasma Lp(a) (21 mg/dl vs. 14 mg/dl, p = 0.11) and fibrinogen (278 mg/dl vs. 291 mg/dl, p = 0.48) levels. The TIMI frame count was not correlated with plasma Lp(a) (r = 0.13, p = 0.25) or fibrinogen (r = -0.14, p = 0.28) levels. Conclusions: Our results show that there is no significant association between SCF and Lp(a) and fibrinogen levels.
dc.identifier.DOI-ID10.5114/pwki.2013.38404
dc.identifier.issn18974295
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17080
dc.language.isoEnglish
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectfibrinogen
dc.subjectlipoprotein A
dc.subjectadult
dc.subjectangiocardiography
dc.subjectarticle
dc.subjectatherosclerosis
dc.subjectblood clot lysis
dc.subjectblood sampling
dc.subjectcardiovascular risk
dc.subjectcontrolled study
dc.subjectcoronary artery
dc.subjectcoronary artery blood flow
dc.subjectcoronary blood vessel
dc.subjectcross-sectional study
dc.subjectdiabetes mellitus
dc.subjectendothelial dysfunction
dc.subjectfamily history
dc.subjectfemale
dc.subjectfibrinogen blood level
dc.subjectheart catheterization
dc.subjectheart infarction
dc.subjecthuman
dc.subjecthyperlipidemia
dc.subjecthypertension
dc.subjectlipoprotein blood level
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectobesity
dc.subjectright coronary artery
dc.subjectsmoking
dc.titlePlasma lipoprotein(a) levels in patients with slow coronary flow
dc.typeArticle

Files

Collections

Scopus Koleksiyonu